The Global Joint Pain Injections Market is estimated to grow at CAGR above 8 % over the forecast time frame 2019-2026 and reach the market value around USD 5.7 billion by 2026. The global market is expected to expand between 2019 and 2026 to include an increase in the number of geriatric patients, an increase in awareness of joint disorders and high medical demands. Increasing the prevalence of joint pain amongst the population, demand for better treatment and development of healthcare infrastructure in various countries around the globe are expected to expand on the joint pain injection market. Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
Free Download Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1352 Increased Obesity Rate Resulting In Joint Pain The risk of obesity for various joint disorders, particularly knee-related, including knee pain and knee osteoarthritis is considerable. World obesity has tripled since 1975, according to a fact sheet published by the WHO. 2016. 2016. Overweight was 1.9 billion, with over 650 million adults being obese. In addition, in 2016, around 41 million children under 5 years of age were obese. National Health and Nutrition Survey (NHANES) 2015-2016 indicates more than 1 in four kids aged between 2 and 19 years had obesity, and about 47 percent of adults had obesity. Increasing patient pool is estimated to increase healthcare spending in developing countries and developed countries on joint pain therapy and, in consequence, to promote the injections market for common pain. Market Snapshots Arthritis is the leading cause of disability in U.S. adults according to the facts published by Arthritis Foundation. About 54 million adults and 300,000 children and babies in the United States suffer from arthritis or rheumatic conditions. By 2040, more than 78 million people in the United States are likely to have arthritis diagnosed by doctors. In addition, the most common type of arthritis is osteoarthritis and affects some 31 million people in the United States. More and more arthritis increases the demand for diseasemodifying treatments which are expected to propel joint pain injections during the forecast period. View Detail Information with Complete TOC@ https://www.acumenresearchandconsulting.com/joint-pain-injections-market
Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
The most common cause of joint pain and major disability and mobility among the population is arthritis. arthritis Current treatment options are not adequate as they are mainly aimed at relieving symptoms and mitigating pain. No drugs, such as osteoarthritis, are possible to cure, reverse or stop disease progression. Some patients are also incapable of finding relief by the treatments available and continue to suffer from pain. Hence, patients with joint pain have a large unmet need. This offers the chance for advance treatment options on the market for joint pain injections. Hyaluronic acid injections are a highly attractive segment of the global pain injection market, followed by corticosteroid injections and other segments in terms of the injection type. This is due to the efficacy of hyaluronic acid injections in treating knee arthritis, which are contraindicated for other treatments. Viscosupplementation with hyaluronic acid in adults with knee osteoarthritis in the area of improved knee pain and function with minimal adverse effects accordingly is superior to intra-articular placebo and other traditional medicine, such as non-steroidal anti-inflammatory medicine(NSAID) published by CADTH. Browse All official Market Research Reports Press Releases@ https://www.acumenresearchandconsulting.com/press-releases Regional Stance Due to a large pool of patients, increased geriatric populations, increased obesity and high acceptance of the region’s advanced treatments for pain alleviation, North America dominated the worldwide joint injection market. During the forecast period, the region is estimated to remain dominant. U.S. FDA approved for the treatment of the knee arthritis viscosis supplementation with hyaluronic acid products. In the next few years, increasing healthcare expenses and investment are also key to boosting the joint pain injection market. The Asia-Pacific joint pain injection market is expected to expand Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
with a major CAGR as join disorders are increased in developing countries and research initiatives are ongoing, and hyaluronic acid products will be manufactured in Japan. Key Players & Strategies Allergan Plc., Pfizer Inc., Sanofi, Ferring, B, Flexion Therapeutics, Inc.., Anika Therapeutics, Inc., SEIKAGAKU CORPORATION, and Chugai Pharmaceutical Co., Ltd. are major actors operating on the common pain injections market. Inc. Key players expand their product portfolio by combining, acquiring and cooperating with leading medical firms that are expected to improve the availability of the products and thus boost the market. Explore Our Market Blog@ https://www.acumenresearchandconsulting.com/blogs TABLE OF CONTENT CHAPTER 1. INDUSTRY OVERVIEW 1.1. Definition and Scope 1.1.1. Definition of Joint Pain Injections 1.1.2. Market Segmentation 1.1.3. List of Abbreviations 1.2. Summary 1.2.1. Market Snapshot 1.2.2. Joint Pain Injections Market By Type 1.2.2.1. Global Joint Pain Injections Market Revenue and Growth Rate Comparison By Type (2015-2026) 1.2.2.2. Global Joint Pain Injections Market Revenue Share By Type in 2017 1.2.2.3. Hyaluronic Acid Injections 1.2.2.4. Corticosteroid Injections 1.2.3. Joint Pain Injections Market By Joint Type Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
1.2.3.1. Global Joint Pain Injections Market Revenue and Growth Rate Comparison By Joint Type (2015-2026) 1.2.3.2. Global Joint Pain Injections Market Revenue Share By Joint Type in 2017 1.2.3.3. Knee and Ankle 1.2.3.4. Shoulder and Elbow 1.2.3.5. Hip Joint 1.2.3.6. Facet Joints of the Spine 1.2.4. Joint Pain Injections Market By Distribution Channel 1.2.4.1. Global Joint Pain Injections Market Revenue and Growth Rate Comparison By Distribution Channel (2015-2026) 1.2.4.2. Global Joint Pain Injections Market Revenue Share By Distribution Channel in 2017 1.2.4.3. Hospital Pharmacies 1.2.4.4. Online Pharmacies 1.2.4.5. Retail Pharmacies 1.2.5. Joint Pain Injections Market by Geography 1.2.5.1. Global Joint Pain Injections Market Revenue and Growth Rate Comparison by Geography (2015-2026) 1.2.5.2. North America Joint Pain Injections Market Revenue and Growth Rate (2015-2026) 1.2.5.3. Europe Joint Pain Injections Market Revenue and Growth Rate (20152026) 1.2.5.4. Asia-Pacific Joint Pain Injections Market Revenue and Growth Rate (2015-2026) 1.2.5.5. Latin America Joint Pain Injections Market Revenue and Growth Rate (2015-2026) 1.2.5.6. Middle East and Africa (MEA) Joint Pain Injections Market Revenue and Growth Rate (2015-2026)
Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS 2.1. Market Drivers 2.2. Restraints and Challenges 2.3. Growth Opportunities 2.4. Porter’s Five Forces Analysis 2.4.1. Bargaining Power of Suppliers 2.4.2. Bargaining Power of Buyers 2.4.3. Threat of Substitute 2.4.4. Threat of New Entrants 2.4.5. Degree of Competition 2.5. Value Chain Analysis 2.6. Cost Structure Analysis 2.6.1. Raw Material and Suppliers 2.6.2. Manufacturing Process Analysis 2.7. Regulatory Compliance 2.8. Competitive Landscape, 2017 2.8.1. Player Positioning Analysis 2.8.2. Key Strategies Adopted By Leading Players CHAPTER 3. MANUFACTURING PLANTS ANALYSIS 3.1. Capacity and Commercial Production Date of Global Joint Pain Injections Major Manufacturers in 2017 3.2. Manufacturing Plants Distribution of Global Joint Pain Injections Major Manufacturers in 2017 3.3. R&D Status and Technology Source of Global Joint Pain Injections Major Manufacturers in 2017 3.4. Raw Materials Sources Analysis of Global Joint Pain Injections Major Manufacturers in 2017
Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
CHAPTER 4. JOINT PAIN INJECTIONS MARKET BY TYPE 4.1. Global Joint Pain Injections Revenue By Type 4.2. Hyaluronic Acid Injections 4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 4.3. Corticosteroid Injections 4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) CHAPTER 5. JOINT PAIN INJECTIONS MARKET BY JOINT TYPE 5.1. Global Joint Pain Injections Revenue By Joint Type 5.2. Knee and Ankle 5.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 5.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 5.3. Shoulder and Elbow 5.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 5.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 5.4. Hip Joint 5.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 5.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 5.5. Facet Joints of the Spine 5.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 5.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) CHAPTER 6. JOINT PAIN INJECTIONS MARKET BY DISTRIBUTION CHANNEL 6.1. Global Joint Pain Injections Revenue By Distribution Channel 6.2. Hospital Pharmacies 6.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 6.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 6.3. Online Pharmacies Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
6.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 6.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 6.4. Retail Pharmacies 6.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 6.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) CHAPTER 7. NORTH AMERICA JOINT PAIN INJECTIONS MARKET BY COUNTRY 7.1. North America Joint Pain Injections Market Revenue and Growth Rate, 2015 – 2026 ($Million) 7.2. North America Joint Pain Injections Market Revenue Share Comparison, 2015 & 2026 (%) 7.3. U.S. 7.3.1. U.S. Joint Pain Injections Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 7.3.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) 7.4. Canada 7.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 7.4.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) 7.5. Mexico 7.5.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 7.5.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) CHAPTER 8. EUROPE JOINT PAIN INJECTIONS MARKET BY COUNTRY 8.1. Europe Joint Pain Injections Market Revenue and Growth Rate, 2015 – 2026 ($Million) 8.2. Europe Joint Pain Injections Market Revenue Share Comparison, 2015 & 2026 (%) 8.3. UK 8.3.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 8.3.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
8.4. Germany 8.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 8.4.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) 8.5. France 8.5.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 8.5.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) 8.6. Spain 8.6.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 8.6.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) 8.7. Rest of Europe 8.7.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 8.7.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) CHAPTER 9. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET BY COUNTRY 9.1. Asia-Pacific Joint Pain Injections Market Revenue and Growth Rate, 2015 – 2026 ($Million) 9.2. Asia-Pacific Joint Pain Injections Market Revenue Share Comparison, 2015 & 2026 (%) 9.3. China 9.3.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 9.3.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) 9.4. Japan 9.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 9.4.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) 9.5. India 9.5.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 9.5.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) 9.6. Australia 9.6.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 9.6.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
9.7. South Korea 9.7.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 9.7.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) 9.8. Rest of Asia-Pacific 9.8.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 9.8.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) CHAPTER 10. LATIN AMERICA JOINT PAIN INJECTIONS MARKET BY COUNTRY 10.1. Latin America Joint Pain Injections Market Revenue and Growth Rate, 2015 – 2026 ($Million) 10.2. Latin America Joint Pain Injections Market Revenue Share Comparison, 2015 & 2026 (%) 10.3. Brazil 10.3.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 10.3.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) 10.4. Argentina 10.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 10.4.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) 10.5. Rest of Latin America 10.5.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 10.5.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) CHAPTER 11. MIDDLE EAST JOINT PAIN INJECTIONS MARKET BY COUNTRY 11.1. Middle East Joint Pain Injections Market Revenue and Growth Rate, 2015 – 2026 ($Million) 11.2. Middle East Joint Pain Injections Market Revenue Share Comparison, 2015 & 2026 (%) 11.3. Saudi Arabia 11.3.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 11.3.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
11.4. UAE 11.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 11.4.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) 11.5. Rest of Middle East 11.5.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 11.5.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) CHAPTER 12. AFRICA JOINT PAIN INJECTIONS MARKET BY COUNTRY 12.1. Africa Joint Pain Injections Market Revenue and Growth Rate, 2015 – 2026 ($Million) 12.2. Africa Joint Pain Injections Market Revenue Share Comparison, 2015 & 2026 (%) 12.3. South Africa 12.3.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 12.3.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) 12.4. Egypt 12.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 12.4.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) 12.5. Rest of Africa 12.5.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million) 12.5.2. Market Revenue and Forecast By End-user, 2015 – 2026 ($Million) CHAPTER 13. COMPANY PROFILE 13.1. Allergan Plc. 13.1.1. Company Snapshot 13.1.2. Overview 13.1.3. Financial Overview 13.1.4. Product Portfolio 13.1.5. Key Developments 13.1.6. Strategies Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
13.2. Pfizer Inc. 13.2.1. Company Snapshot 13.2.2. Overview 13.2.3. Financial Overview 13.2.4. Product Portfolio 13.2.5. Key Developments 13.2.6. Strategies 13.3. Sanofi 13.3.1. Company Snapshot 13.3.2. Overview 13.3.3. Financial Overview 13.3.4. Product Portfolio 13.3.5. Key Developments 13.3.6. Strategies 13.4. Ferring B.V. 13.4.1. Company Snapshot 13.4.2. Overview 13.4.3. Financial Overview 13.4.4. Product Portfolio 13.4.5. Key Developments 13.4.6. Strategies 13.5. Flexion Therapeutics, Inc. 13.5.1. Company Snapshot 13.5.2. Overview 13.5.3. Financial Overview 13.5.4. Product Portfolio 13.5.5. Key Developments 13.5.6. Strategies 13.6. Anika Therapeutics, Inc 13.6.1. Company Snapshot 13.6.2. Overview Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
13.6.3. Financial Overview 13.6.4. Product Portfolio 13.6.5. Key Developments 13.6.6. Strategies 13.7. SEIKAGAKU CORPORATION 13.7.1. Company Snapshot 13.7.2. Overview 13.7.3. Financial Overview 13.7.4. Product Portfolio 13.7.5. Key Developments 13.7.6. Strategies 13.8. Chugai Pharmaceutical Co., Ltd. 13.8.1. Company Snapshot 13.8.2. Overview 13.8.3. Financial Overview 13.8.4. Product Portfolio 13.8.5. Key Developments 13.8.6. Strategies 13.9. Others 13.9.1. Company Snapshot 13.9.2. Overview 13.9.3. Financial Overview 13.9.4. Product Portfolio 13.9.5. Key Developments 13.9.6. Strategies CHAPTER 14. RESEARCH APPROACH 14.1. Research Methodology 14.1.1. Initial Data Search 14.1.2. Secondary Research Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
14.1.3. Primary Research 14.2. Assumptions and Scope
The report is readily available and can be dispatched immediately after payment confirmation. To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/1352
Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157